Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.

Hsiang, David J

Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. [electronic resource] - Archives of surgery (Chicago, Ill. : 1960) Sep 2007 - 855-61; discussion 860-1 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

0004-0010

10.1001/archsurg.142.9.855 doi


Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Axilla
Breast Neoplasms--drug therapy
Carboplatin--administration & dosage
Contrast Media
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Gadolinium DTPA
Humans
Lymph Node Excision
Lymph Nodes--pathology
Lymphatic Metastasis
Magnetic Resonance Imaging--methods
Mastectomy
Mastectomy, Segmental
Middle Aged
Neoadjuvant Therapy
Paclitaxel--administration & dosage
Predictive Value of Tests
Receptor, ErbB-2--analysis
Retrospective Studies
Sensitivity and Specificity
Trastuzumab
Treatment Outcome